drugset / Trial / NCT01976572

Drug-Drug Interaction Study to Evaluate the Effect of Colestilan on the Pharmacokinetics of Single Doses of Candesartan Cilexetil in Healthy Subjects

NCT01976572

Phase 1 Completed 18 enrolled Tanabe Pharma Corporation
RandomizedCrossoverOpen-labelTreatment

Summary

The primary objective is to assess the effects of colestilan on the pharmacokinetic profile of candesartan cilexetil when administered at the same time as, 1 hour before, and 3 hours after the first daily dose of colestilan administered at doses of 5 g three times daily compared to administration of candesartan cilexetil alone, in healthy subjects.

Timeline

Start
2013-10
Primary completion
2014-01
Completion
2014-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator COLESTILAN CHLORIDE Other / unclassified 5 g Oral
Comparator Candesartan Unknown 16 mg Oral